Trends in older adult psoriasis outpatient health care practices in the united states

Journal of Drugs in Dermatology

Volumn 11, Issue 8, 2012, Pages 957-962

  Wong, Jillian W ^a,b   Davis, Scott A ^c   Feldman, Steven R ^c   Koo, John Y M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; CLOBETASOL; COAL TAR; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETRETIN; ETRETINATE; FLUOCINONIDE; HYDROCORTISONE; METHOTREXATE; METHOXSALEN; METHYLPREDNISOLONE; PIMECROLIMUS; PREDNISONE; PSORALEN; TRIAMCINOLONE; ULOBETASOL PROPIONATE;

ADULT; AGED; ARTICLE; FEMALE; HEALTH CARE PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCRIPTION; PSORIASIS; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; BETAMETHASONE; CALCITRIOL; CLOBETASOL; COAL TAR; DERMATOLOGIC AGENTS; DERMATOLOGY; FAMILY PRACTICE; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INTERNAL MEDICINE; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; UNITED STATES; YOUNG ADULT;

EID: 84866180717     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Randall T. Demographers ponder the aging of the aged and await unprecedented looming elder boom. JAMA. 1993;269:2331-2332.
2. Kreitzer MJ, Leider RJ. What's Next? Exploring Purpose in the Second Half of Life. American Journal of Nursing. 2009;109:24-27.
3. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136-139.
4. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141:1537-1541.
5. Christophers E. Psoriasis: epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314-320.
6. Bell LM, Sedlack R, Beard CM, et al. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol.1991;127:183-187.
7. Smith ES, Fleischer Jr AB, Feldman SR. Geriatric Dermatology, Part 1: Demographics of aging and skin disease. Clinics in Geriatric Medicine. 2001;17:631-641.
8. Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? International Journal of Dermatology. 2012;51:53-58.
9. Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 2009;60:478-481.
10. Centers for Disease Control and Prevention. Table 1. Resident population, by age, sex, race, and Hispanic origin: United States, selected years 1950-2009. Available at: http://www.cdc.gov/nchs/data/hus/2011/001.pdf. Accessed May 18, 2012.
11. Wong JW, Guerra A, Koo JYM. Introducing '"Dermatogeriatrics": The Need for Geriatric Dermatology as a Subspecialty. Más Dermatología. Actualidad y Avances. 2011;16:2-3.
12. Wong JW, Koo JYM. The Unique Impact of Psoriasis on the Geriatric Population. Psoriasis Forum. 2012;18:15-21.
13. Sampogna F, Chren MM, Melchi CF, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. British Journal of Dermatology. 2006;154:325-331.
14. Lebwohl M, Ali S. Treatment of Psoriasis: Pt 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45: 487-98.
15. Horn EJ, Fox KM, Patel V, et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57:957-962.
16. Coskey RJ. Adverse effects of corticosteroids, I: topical and intralesional. Clin Dermatol. 1986;4:155-160.
17. Kligman AM. Adverse effects of topical corticosteroids, In: Christophers E, Schopf E, Kligman AM, et al., eds. Topical corticosteroid therapy: a novel approach to safer drugs. New York, NY: Raven Press. 1988:181-187.
18. du Vivier A, Stoughton RB. Tachyphylaxis to the actin of topically applied corticosteroids. Arch Dermatol. 1975;111:581-583.
19. Singh G, Singh PK. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression. Int J Dermatol. 1986;25:324-326.
20. Weston WL, Fennessey PV, Morelli J, et al. Comparison of hypothalamuspituitary- adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol. 1988;90:532-535.
21. May P, Stein ES, Ryler RJ, et al. Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch Intern Med. 1976;136:612-613.
22. Tay YK, Tham SN. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases. Int J Dermatol.1997;36: 266-71
23. Galloway JB, Hyrich KL, Mercer LK, et al. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology. 2011;50:124-131.
24. Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2011;65:537-545.